Correction: Molecular characterization and risk analysis of Giardia duodenalis assemblages in corticosteroid-treated and non-treated patients in Ismailia, Arab Republic of Egypt
- Open Access
- 01.12.2025
- Correction
Erschienen in:
Correction: Gut Pathogens (2024) 16:74 https://doi.org/10.1186/s13099-024-00668-y
In this article [1], inadvertently, dashes were converted to beta symbol. The incorrect and corrected Table 4 are given below.
Anzeige
Incorrect Table 4:
Table 4
Giardia duodenalis assemblages detected in patients on corticosteroid therapy (POCT) and controls (CONT)
No. | Group | Serial | Symp. Assoc. | tpi | bg | gdh | Assemblage detected | positive/total |
|---|---|---|---|---|---|---|---|---|
1 | POCT | A21 | 1 | ββ | β | B | B | 15/21 |
2 | POCT | A22 | 1 | β | β | β | β | |
3 | POCT | A23 | 2 | β | β | β | β | |
4 | POCT | A24 | 2 | β | β | B | B | |
5 | POCT | A25 | 2 | B | β | β | B | |
6 | POCT | A26 | 2 | β | β | β | β | |
7 | POCT | A27 | 2 | β | β | B | B | |
8 | POCT | A28 | 1 | A | β | β | A | |
9 | POCT | A29 | 2 | A | β | β | A | |
10 | POCT | A30 | 1 | β | β | AII | A | |
11 | POCT | A31 | 1 | β | β | β | β | |
12 | POCT | A32 | 2 | A | β | B | A + B | |
13 | POCT | A33 | 2 | A | β | β | A | |
14 | POCT | A34 | 2 | A | β | B | A + B | |
15 | POCT | A35 | 2 | Aa | ββ | β | A | |
16 | POCT | A36 | 2 | ββ | β | AII | A | |
17 | POCT | A37 | 1 | β | β | β | β | |
18 | POCT | A38 | 1 | B | β | β | B | |
19 | POCT | A39 | 1 | A | β | B | A + B | |
20 | POCT | A40 | 1 | β | β | β | β | |
21 | POCT | A41 | 2 | A | β | ββ | A | |
22 | CONT | B01 | 1 | β | B | AII | A + B | 23/31 |
23 | CONT | B02 | 1 | β | β | β | β | |
24 | CONT | B03 | 1 | B | B | B | B | |
25 | CONT | B04 | 1 | β | β | β | β | |
26 | CONT | B05 | 1 | β | β | β | β | |
27 | CONT | B06 | 1 | A | β | β | A | |
28 | CONT | B07 | 1 | β | β | β | β | |
29 | CONT | B08 | 1 | β | β | β | β | |
30 | CONT | B09 | 1 | β | β | β | β | |
31 | CONT | B10 | 1 | β | β | β | β | |
32 | CONT | B11 | 1 | β | β | β | β | |
33 | CONT | C12 | 2 | A | AII | AII | A | |
34 | CONT | C13 | 2 | B | B | B | B | |
35 | CONT | C14 | 2 | B | B | AII | A + B | |
36 | CONT | C15 | 2 | A | B | β | A + B | |
37 | CONT | C16 | 2 | B | AII | ββ | A + B | |
38 | CONT | C17 | 2 | B | B | E | B + E | |
39 | CONT | C18 | 2 | B | B | β | B | |
40 | CONT | C19 | 2 | B | B | β | B | |
41 | CONT | C20 | 2 | B | B | B | B | |
42 | CONT | D42 | 1 | β | B | E | B + E | |
43 | CONT | D43 | 1 | – | B | – | B | |
44 | CONT | D44 | 1 | A | AII | – | A | |
45 | CONT | D45 | 2 | – | B | – | B | |
46 | CONT | D46 | 2 | B | Ba | B | B | |
47 | CONT | D47 | 2 | B | Ba | AII | A + B | |
48 | CONT | D48 | 2 | B | B | B | B | |
49 | CONT | D49 | 2 | B | B | B | B | |
50 | CONT | D50 | 1 | B | B | B | B | |
51 | CONT | D51 | 1 | B | Ba | E | B + E | |
52 | CONT | D52 | 2 | A | B | – | A + B | |
Total | 29/52 | 22/52 | 22/52 | 38/52 | ||||
Correct Table 4:
Table 4
Giardia duodenalis assemblages detected in patients on corticosteroid therapy (POCT) and controls (CONT)
No. | Group | Serial | Symp. Assoc. | tpi | bg | gdh | Assemblage detected | Positive/total |
|---|---|---|---|---|---|---|---|---|
1 | POCT | A21 | 1 | – | – | B | B | 15/21 |
2 | POCT | A22 | 1 | – | – | – | – | |
3 | POCT | A23 | 2 | – | – | – | – | |
4 | POCT | A24 | 2 | – | – | B | B | |
5 | POCT | A25 | 2 | B | – | – | B | |
6 | POCT | A26 | 2 | – | – | – | – | |
7 | POCT | A27 | 2 | – | – | B | B | |
8 | POCT | A28 | 1 | A | – | – | A | |
9 | POCT | A29 | 2 | A | – | – | A | |
10 | POCT | A30 | 1 | – | – | AII | A | |
11 | POCT | A31 | 1 | – | – | – | – | |
12 | POCT | A32 | 2 | A | – | B | A + B | |
13 | POCT | A33 | 2 | A | – | – | A | |
14 | POCT | A34 | 2 | A | – | B | A + B | |
15 | POCT | A35 | 2 | Aa | – | – | A | |
16 | POCT | A36 | 2 | – | – | AII | A | |
17 | POCT | A37 | 1 | – | – | – | – | |
18 | POCT | A38 | 1 | B | – | – | B | |
19 | POCT | A39 | 1 | A | – | B | A + B | |
20 | POCT | A40 | 1 | – | – | – | – | |
21 | POCT | A41 | 2 | A | – | – | A | |
22 | CONT | B01 | 1 | – | B | AII | A + B | 23/31 |
23 | CONT | B02 | 1 | – | – | – | – | |
24 | CONT | B03 | 1 | B | B | B | B | |
25 | CONT | B04 | 1 | – | – | – | – | |
26 | CONT | B05 | 1 | – | – | – | – | |
27 | CONT | B06 | 1 | A | – | – | A | |
28 | CONT | B07 | 1 | – | – | – | – | |
29 | CONT | B08 | 1 | – | – | – | – | |
30 | CONT | B09 | 1 | – | – | – | – | |
31 | CONT | B10 | 1 | – | – | – | – | |
32 | CONT | B11 | 1 | – | – | – | – | |
33 | CONT | C12 | 2 | A | AII | AII | A | |
34 | CONT | C13 | 2 | B | B | B | B | |
35 | CONT | C14 | 2 | B | B | AII | A + B | |
36 | CONT | C15 | 2 | A | B | – | A + B | |
37 | CONT | C16 | 2 | B | AII | – | A + B | |
38 | CONT | C17 | 2 | B | B | E | B + E | |
39 | CONT | C18 | 2 | B | B | – | B | |
40 | CONT | C19 | 2 | B | B | – | B | |
41 | CONT | C20 | 2 | B | B | B | B | |
42 | CONT | D42 | 1 | – | B | E | B + E | |
43 | CONT | D43 | 1 | – | B | – | B | |
44 | CONT | D44 | 1 | A | AII | – | A | |
45 | CONT | D45 | 2 | – | B | – | B | |
46 | CONT | D46 | 2 | B | Ba | B | B | |
47 | CONT | D47 | 2 | B | Ba | AII | A + B | |
48 | CONT | D48 | 2 | B | B | B | B | |
49 | CONT | D49 | 2 | B | B | B | B | |
50 | CONT | D50 | 1 | B | B | B | B | |
51 | CONT | D51 | 1 | B | Ba | E | B + E | |
52 | CONT | D52 | 2 | A | B | – | A + B | |
Total | 29/52 | 22/52 | 22/52 | 38/52 | ||||
The original article has been corrected.
Anzeige
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
